Thomas H Cartwright Selected Research

Adjuvant Chemotherapy

12/2012

Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thomas H Cartwright Research Topics

Disease

7	Colorectal Neoplasms (Colorectal Cancer) 06/2013 - 05/2008
5	Neoplasms (Cancer) 01/2017 - 01/2002
2	Pancreatic Neoplasms (Pancreatic Cancer) 09/2018 - 01/2002
2	Hypertension (High Blood Pressure) 01/2013 - 12/2012
1	Cardiotoxicity 01/2017
1	Diarrhea 01/2017
1	Leukopenia 01/2017
1	Nausea 01/2017
1	Vomiting 01/2017
1	Mucositis 01/2017
1	Dihydropyrimidine Dehydrogenase Deficiency 01/2017
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2015
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2013
1	Headache (Headaches) 01/2013
1	Carcinoma (Carcinomatosis) 12/2012
1	Colonic Neoplasms (Colon Cancer) 12/2012
1	Neutropenia 12/2012
1	Pain (Aches) 01/2002

Drug/Important Bio-Agent (IBA)

5	Capecitabine (Xeloda)FDA Link 01/2017 - 01/2002
4	Bevacizumab (Avastin)FDA Link 01/2013 - 09/2012
3	Fluorouracil (Carac)FDA LinkGeneric 01/2017 - 09/2012
2	Leucovorin (Folinic Acid)FDA Link 12/2012 - 09/2012
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2012 - 09/2012
2	Panitumumab (Vectibix)FDA Link 09/2012 - 05/2008
2	Cetuximab (Erbitux)FDA Link 09/2012 - 05/2008
1	130-nm albumin-bound paclitaxelIBA 09/2018
1	Gemcitabine FDA Link 09/2018
1	folfirinoxIBA 09/2018
1	EnzymesIBA 01/2017
1	uridine triacetateIBA 01/2017
1	Carboplatin (JM8)FDA LinkGeneric 07/2015
1	Cisplatin (Platino)FDA LinkGeneric 07/2015
1	Dihydrotachysterol (AT 10)IBA 07/2014
1	Angiogenesis InhibitorsIBA 06/2013
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2013
1	Axitinib (AG 013736)IBA 01/2013
1	XELOXIBA 12/2012
1	Irinotecan (Camptosar)FDA LinkGeneric 09/2012
1	Analgesics (Analgesic Drugs)IBA 01/2002

Therapy/Procedure

7	Drug Therapy (Chemotherapy) 09/2018 - 05/2008
2	Therapeutics 01/2013 - 09/2012
1	Combination Drug Therapy (Combination Chemotherapy) 09/2018
1	Time-to-Treatment 09/2018
1	Adjuvant Chemotherapy 12/2012